|Day Low/High||29.20 / 29.74|
|52 Wk Low/High||28.00 / 37.61|
Eli Lilly's confirmation of acquisition action could make pharmaceuticals an attractive investment space.
Exelixis Inc. and Aratana Therapeutics in particular surge after posting solid results Thursday.
The limited technical data for the recent Eli Lilly spinoff indicate buyers came in early and appear to be holding.